Approved Studies sorted on Review Date
ACTIVE STUDY: Resveratrol for the prevention of bone loss in postmenopausal women
Approval Status: | Approved |
---|---|
Number: | 121 |
Submission Date | January 17, 2024 |
Is this study IRB-Approved? | Yes |
Date of NEXT IRB Review: | [294] |
Full Study Name: | Resveratrol for the prevention of bone loss in postmenopausal women |
Short Study Name: | Resveratrol for the prevention of bone loss in postmenopausal women |
College / Affiliation | College of Health Sciences |
Relevant Research Categories | [328] |
Location of Study: | University of Delaware Main Campus, Newark, DE 19716, University of Delaware STAR Campus, 540 S College Ave, Newark, DE 19713 |
Description of Study: |
The aim of this study is to determine the effects of resveratrol, a natural antioxidant found in various foods such as berries on bone health in postmenopausal women. Women will be randomly assigned to two groups: 1) the placebo group and 2) the resveratrol group. The resveratrol group will receive 500 mg resveratrol daily, and placebo group will receive placebo pills. Both groups will also receive 500 mg calcium plus 400 IU vitamin D daily. |
Will participants be compensated for participation? | |
Inclusion and Exclusion Criteria: |
If you are a woman 1-10 years postmenopausal, and have not been diagnosed with osteoporosis, you may be eligible to participate in our study! |
“How to Apply” Description: |
If you are interested, please call 302-831-7218 or email ChaiResearchLab@udel.edu |
How to Apply Link: | |
How to Apply Email: | |
Contact Name: | Bingqing |
Contact Last | Chai |
Contact Email: | ChaiResearchLab@udel.edu |
Phone: | 302-831-7218 |
PI Name: | Sheau Ching |
PI Last | Chai |
PI Email: | scchai@udel.edu |